News

Agnes Streissler as new representative of ZIT in LISA VR's advisory board

With immediate effect Agnes Streissler represents ZIT in LISA VR’s advisory board. Since October 2007 she heads the…

IMP: Molecular Glue with New Effect

IMP: Molecular Glue with New Effect

Researchers at the Institute of Molecular Pathology (IMP)

in Vienna clarify cause…

Sanochemia: Final results for 2006/2007 fiscal year

Sanochemia: Final results for 2006/2007 fiscal year Sales revenues increase by 6% in core segments – one-off impairment…

AAS: Novartis Research Prize for Karel Riha

Karel Riha, a Young Investigator at the GMI, has been awarded the 2007 Novartis Research Prize in Biology. The Novartis…

Intercell (ICLL) and the PATH malaria vaccine initiative announce new collaboration for a vaccine against m...

Intercell (ICLL) and the PATH malaria vaccine initiative announce new collaboration for a vaccine against malaria

Intercell receives manufacturer's licence for future commercial manufacturing of its vaccine against Japane...

Intercell receives manufacturer's licence for future commercial manufacturing of its vaccine against Japanese…

60th anniversary of Boehringer Ingelheim in Austria

60th anniversary of Boehringer Ingelheim in Austria

>> High-ranking politicians highlight the company’s importance for…

Intercell's results on a novel pneumococcal protein-based vaccine published in the Journal of Experimental ...

Intercell's results on a novel pneumococcal protein-based vaccine published in the Journal of Experimental Medicine

Marinomed Signs Collaboration with Boehringer Ingelheim for Anti-Viral Nasal Spray Against Common Cold

Marinomed Signs Collaboration with Boehringer Ingelheim for Anti-Viral Nasal Spray Against Common Cold

Intercell finalizes submission of US Biological License Application (BLA) to FDA for licensure of Japanese ...

Intercell finalizes submission of US Biological License Application (BLA) to FDA for licensure of Japanese Encephalitis…

Sanochemia: Preliminary figures for the 2006/2007 fiscal year (1. 10. 2006 - 30. 9. 2007)

Sanochemia: Preliminary figures for the 2006/2007 fiscal year (1. 10. 2006 - 30. 9. 2007)

>> Consolidation of AlcaSynn…

PHADIA invests in VBC Genomics

PHADIA Holding AB, Sweden, a global market leader in in-vitro allergy diagnostics acquires a 24.9% holding in…

The sender takes full responsibility for the content of this news item. Content may include forward-looking statements which, at the time they were made, were based on expectations of future events. Readers are cautioned not to rely on these forward-looking statements.

As a life sciences organization based in Vienna, would you like us to promote your news and events? If so, please send your contributions to news(at)lisavienna.at.